Resistance of Gram-Negative Bacilli to Gentamicin

Strains of Pseudomonas aeruginosa resistant to gentamicin have appeared during three years of extensive use of this antibiotic in the Winnipeg General Hospital. During October and November of 1970, isolates of P. aeruginosa sensitive to gentamicin were recovered from 62 patients. Thirty-one of these...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1971-12, Vol.124 (Supplement-1), p.S264-S270
Hauptverfasser: Snelling, Charles F. T., Ronald, Allan R., Cates, Claudette Y., Forsythe, William C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S270
container_issue Supplement-1
container_start_page S264
container_title The Journal of infectious diseases
container_volume 124
creator Snelling, Charles F. T.
Ronald, Allan R.
Cates, Claudette Y.
Forsythe, William C.
description Strains of Pseudomonas aeruginosa resistant to gentamicin have appeared during three years of extensive use of this antibiotic in the Winnipeg General Hospital. During October and November of 1970, isolates of P. aeruginosa sensitive to gentamicin were recovered from 62 patients. Thirty-one of these patients received gentamicin; in five patients, strains of P. aeruginosa resistant to gentamicin were isolated after therapy. Four patients received gentamicin parenterally, and one topically. No gentamicin-resistant P. aeruginosa appeared in the 31 patients not given gentamicin. Only two of 622 isolates of Enterobacteriaceae were resistant. Of 108 burns treated between October, 1968 and December, 1970 with daily prophylactic topical applications of gentamicin, 24 were colonized with P. aeruginosa; the organisms in seven patients were initially resistant. Pyocine typing on all resistant organisms from both groups of patients suggests that episodes of cross-infection with gentamicin-resistant strains have occurred in patients with burns. No persisting hospital reservoir of gentamicin-resistant organisms has been identified.
doi_str_mv 10.1093/infdis/124.Supplement_1.S264
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_81195412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30110860</jstor_id><sourcerecordid>30110860</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-6b545ec80ff207eb3fb18dac3b0924099898500c07d7ea851c654023066027c83</originalsourceid><addsrcrecordid>eNpNkMlKA0EQhhtRNC6PIMxBvE1S1dv0gBeNJpG4gAuIl6an0yMdZ4nTE9G3dyQheqrDV3_9xUfICUIfIWUDX-UzHwZIef9xuVgUrnRVq7H_SCXfIj0ULImlRLZNegCUxqjSdI_shzAHAM5kskt2BQBKKnoEH1zwoTWVdVGdR-PGlPGdezOt_3TRhbG-KHzU1tG46zClt746JDu5KYI7Ws8D8jy6ehpO4pv78fXw_Ca2nKs2lpngwlkFeU4hcRnLM1QzY1kGKeWQpipV3RcWklnijBJopeBAGUgJNLGKHZDT1d1FU38sXWh16YN1RWEqVy-DVoip4Ei7xbPVom3qEBqX60XjS9N8awT9a0yvjOnOmP5vTP8a6-LH655lVrrZJrxW9Mfnoa2bDWaACEpCx-MV7zS6rw03zbuWCUuEnry8ajUeXd4Op1M9ZT8J14Rn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81195412</pqid></control><display><type>article</type><title>Resistance of Gram-Negative Bacilli to Gentamicin</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><creator>Snelling, Charles F. T. ; Ronald, Allan R. ; Cates, Claudette Y. ; Forsythe, William C.</creator><creatorcontrib>Snelling, Charles F. T. ; Ronald, Allan R. ; Cates, Claudette Y. ; Forsythe, William C.</creatorcontrib><description>Strains of Pseudomonas aeruginosa resistant to gentamicin have appeared during three years of extensive use of this antibiotic in the Winnipeg General Hospital. During October and November of 1970, isolates of P. aeruginosa sensitive to gentamicin were recovered from 62 patients. Thirty-one of these patients received gentamicin; in five patients, strains of P. aeruginosa resistant to gentamicin were isolated after therapy. Four patients received gentamicin parenterally, and one topically. No gentamicin-resistant P. aeruginosa appeared in the 31 patients not given gentamicin. Only two of 622 isolates of Enterobacteriaceae were resistant. Of 108 burns treated between October, 1968 and December, 1970 with daily prophylactic topical applications of gentamicin, 24 were colonized with P. aeruginosa; the organisms in seven patients were initially resistant. Pyocine typing on all resistant organisms from both groups of patients suggests that episodes of cross-infection with gentamicin-resistant strains have occurred in patients with burns. No persisting hospital reservoir of gentamicin-resistant organisms has been identified.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/124.Supplement_1.S264</identifier><identifier>PMID: 5001625</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Agar ; Antibiotics ; Burns ; Burns - drug therapy ; Cream ; Cross Infection - prevention &amp; control ; Drug Resistance ; Enterobacteriaceae ; Enterobacteriaceae - drug effects ; Gentamicins - administration &amp; dosage ; Gentamicins - pharmacology ; Gentamicins - therapeutic use ; Humans ; Infections ; Labor standards ; Microbial colonization ; Pseudomonas ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - isolation &amp; purification ; Pseudomonas Infections - drug therapy ; Session VI: Clinical Experience</subject><ispartof>The Journal of infectious diseases, 1971-12, Vol.124 (Supplement-1), p.S264-S270</ispartof><rights>Copyright 1971 University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-6b545ec80ff207eb3fb18dac3b0924099898500c07d7ea851c654023066027c83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30110860$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30110860$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27903,27904,57995,58228</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5001625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Snelling, Charles F. T.</creatorcontrib><creatorcontrib>Ronald, Allan R.</creatorcontrib><creatorcontrib>Cates, Claudette Y.</creatorcontrib><creatorcontrib>Forsythe, William C.</creatorcontrib><title>Resistance of Gram-Negative Bacilli to Gentamicin</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Strains of Pseudomonas aeruginosa resistant to gentamicin have appeared during three years of extensive use of this antibiotic in the Winnipeg General Hospital. During October and November of 1970, isolates of P. aeruginosa sensitive to gentamicin were recovered from 62 patients. Thirty-one of these patients received gentamicin; in five patients, strains of P. aeruginosa resistant to gentamicin were isolated after therapy. Four patients received gentamicin parenterally, and one topically. No gentamicin-resistant P. aeruginosa appeared in the 31 patients not given gentamicin. Only two of 622 isolates of Enterobacteriaceae were resistant. Of 108 burns treated between October, 1968 and December, 1970 with daily prophylactic topical applications of gentamicin, 24 were colonized with P. aeruginosa; the organisms in seven patients were initially resistant. Pyocine typing on all resistant organisms from both groups of patients suggests that episodes of cross-infection with gentamicin-resistant strains have occurred in patients with burns. No persisting hospital reservoir of gentamicin-resistant organisms has been identified.</description><subject>Agar</subject><subject>Antibiotics</subject><subject>Burns</subject><subject>Burns - drug therapy</subject><subject>Cream</subject><subject>Cross Infection - prevention &amp; control</subject><subject>Drug Resistance</subject><subject>Enterobacteriaceae</subject><subject>Enterobacteriaceae - drug effects</subject><subject>Gentamicins - administration &amp; dosage</subject><subject>Gentamicins - pharmacology</subject><subject>Gentamicins - therapeutic use</subject><subject>Humans</subject><subject>Infections</subject><subject>Labor standards</subject><subject>Microbial colonization</subject><subject>Pseudomonas</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - isolation &amp; purification</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Session VI: Clinical Experience</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1971</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMlKA0EQhhtRNC6PIMxBvE1S1dv0gBeNJpG4gAuIl6an0yMdZ4nTE9G3dyQheqrDV3_9xUfICUIfIWUDX-UzHwZIef9xuVgUrnRVq7H_SCXfIj0ULImlRLZNegCUxqjSdI_shzAHAM5kskt2BQBKKnoEH1zwoTWVdVGdR-PGlPGdezOt_3TRhbG-KHzU1tG46zClt746JDu5KYI7Ws8D8jy6ehpO4pv78fXw_Ca2nKs2lpngwlkFeU4hcRnLM1QzY1kGKeWQpipV3RcWklnijBJopeBAGUgJNLGKHZDT1d1FU38sXWh16YN1RWEqVy-DVoip4Ei7xbPVom3qEBqX60XjS9N8awT9a0yvjOnOmP5vTP8a6-LH655lVrrZJrxW9Mfnoa2bDWaACEpCx-MV7zS6rw03zbuWCUuEnry8ajUeXd4Op1M9ZT8J14Rn</recordid><startdate>197112</startdate><enddate>197112</enddate><creator>Snelling, Charles F. T.</creator><creator>Ronald, Allan R.</creator><creator>Cates, Claudette Y.</creator><creator>Forsythe, William C.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197112</creationdate><title>Resistance of Gram-Negative Bacilli to Gentamicin</title><author>Snelling, Charles F. T. ; Ronald, Allan R. ; Cates, Claudette Y. ; Forsythe, William C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-6b545ec80ff207eb3fb18dac3b0924099898500c07d7ea851c654023066027c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1971</creationdate><topic>Agar</topic><topic>Antibiotics</topic><topic>Burns</topic><topic>Burns - drug therapy</topic><topic>Cream</topic><topic>Cross Infection - prevention &amp; control</topic><topic>Drug Resistance</topic><topic>Enterobacteriaceae</topic><topic>Enterobacteriaceae - drug effects</topic><topic>Gentamicins - administration &amp; dosage</topic><topic>Gentamicins - pharmacology</topic><topic>Gentamicins - therapeutic use</topic><topic>Humans</topic><topic>Infections</topic><topic>Labor standards</topic><topic>Microbial colonization</topic><topic>Pseudomonas</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - isolation &amp; purification</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Session VI: Clinical Experience</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Snelling, Charles F. T.</creatorcontrib><creatorcontrib>Ronald, Allan R.</creatorcontrib><creatorcontrib>Cates, Claudette Y.</creatorcontrib><creatorcontrib>Forsythe, William C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Snelling, Charles F. T.</au><au>Ronald, Allan R.</au><au>Cates, Claudette Y.</au><au>Forsythe, William C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resistance of Gram-Negative Bacilli to Gentamicin</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1971-12</date><risdate>1971</risdate><volume>124</volume><issue>Supplement-1</issue><spage>S264</spage><epage>S270</epage><pages>S264-S270</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Strains of Pseudomonas aeruginosa resistant to gentamicin have appeared during three years of extensive use of this antibiotic in the Winnipeg General Hospital. During October and November of 1970, isolates of P. aeruginosa sensitive to gentamicin were recovered from 62 patients. Thirty-one of these patients received gentamicin; in five patients, strains of P. aeruginosa resistant to gentamicin were isolated after therapy. Four patients received gentamicin parenterally, and one topically. No gentamicin-resistant P. aeruginosa appeared in the 31 patients not given gentamicin. Only two of 622 isolates of Enterobacteriaceae were resistant. Of 108 burns treated between October, 1968 and December, 1970 with daily prophylactic topical applications of gentamicin, 24 were colonized with P. aeruginosa; the organisms in seven patients were initially resistant. Pyocine typing on all resistant organisms from both groups of patients suggests that episodes of cross-infection with gentamicin-resistant strains have occurred in patients with burns. No persisting hospital reservoir of gentamicin-resistant organisms has been identified.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>5001625</pmid><doi>10.1093/infdis/124.Supplement_1.S264</doi></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1971-12, Vol.124 (Supplement-1), p.S264-S270
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_81195412
source MEDLINE; Jstor Complete Legacy
subjects Agar
Antibiotics
Burns
Burns - drug therapy
Cream
Cross Infection - prevention & control
Drug Resistance
Enterobacteriaceae
Enterobacteriaceae - drug effects
Gentamicins - administration & dosage
Gentamicins - pharmacology
Gentamicins - therapeutic use
Humans
Infections
Labor standards
Microbial colonization
Pseudomonas
Pseudomonas aeruginosa
Pseudomonas aeruginosa - drug effects
Pseudomonas aeruginosa - isolation & purification
Pseudomonas Infections - drug therapy
Session VI: Clinical Experience
title Resistance of Gram-Negative Bacilli to Gentamicin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A19%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resistance%20of%20Gram-Negative%20Bacilli%20to%20Gentamicin&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Snelling,%20Charles%20F.%20T.&rft.date=1971-12&rft.volume=124&rft.issue=Supplement-1&rft.spage=S264&rft.epage=S270&rft.pages=S264-S270&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/124.Supplement_1.S264&rft_dat=%3Cjstor_proqu%3E30110860%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81195412&rft_id=info:pmid/5001625&rft_jstor_id=30110860&rfr_iscdi=true